← Product Code [JWT](/submissions/MI/subpart-d%E2%80%94serological-reagents/JWT) · K760830

# ASPERGILLUS MYCELIAL ANTIGEN (K760830)

_I M, Inc. · JWT · Nov 1, 1976 · Microbiology · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/IM/subpart-d%E2%80%94serological-reagents/JWT/K760830

## Device Facts

- **Applicant:** I M, Inc.
- **Product Code:** [JWT](/submissions/MI/subpart-d%E2%80%94serological-reagents/JWT.md)
- **Decision Date:** Nov 1, 1976
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 866.3040
- **Device Class:** Class 1
- **Review Panel:** Microbiology

## Regulatory Identification

Aspergillus spp. serological reagents are devices that consist of antigens and antisera used in various serological tests to identify antibodies to Aspergillus spp. in serum. The identification aids in the diagnosis of aspergillosis caused by fungi belonging to the genus Aspergillus. Aspergillosis is a disease marked by inflammatory granulomatous (tumor-like) lessions in the skin, ear, eyeball cavity, nasal sinuses, lungs, and occasionally the bones.

---

**Source:** [https://fda.innolitics.com/submissions/IM/subpart-d%E2%80%94serological-reagents/JWT/K760830](https://fda.innolitics.com/submissions/IM/subpart-d%E2%80%94serological-reagents/JWT/K760830)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com